Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/1403
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Silva, H.A.en_US
dc.contributor.authorHewavisenthi, J.en_US
dc.contributor.authorWijesiriwardena, B.en_US
dc.contributor.authorFonseka, M.M.D.en_US
dc.date.accessioned2014-10-29T09:18:22Z
dc.date.available2014-10-29T09:18:22Z
dc.date.issued1999en_US
dc.identifier.citationThe Ceylon Medical Journal. 1999; 44(4): pp.188-189en_US
dc.identifier.issn0009-0875 (Print)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/1403
dc.description.abstractNo Abstract Available
dc.publisherSri Lanka Medical Associationen_US
dc.subjectMethyldopaen_US
dc.subjectHypertension-drug therapy
dc.subjectMethyldopa-adverse effects
dc.subjectMethyldopa-contraindications
dc.subjectAntihypertensive Agents
dc.subjectAntihypertensive Agents-adverse effects
dc.titleMethyldopa use should be restricteden_US
dc.typeLetteren_US
dc.identifier.departmentPharmacologyen_US
dc.identifier.departmentPathologyen_US
dc.creator.corporateauthorSri Lanka Medical Associationen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.